Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech Valuation -- Ignore unavailable to you. Want to Upgrade?

To: BulbaMan who wrote (4980)	11/20/2001 8:41:06 PM
From: keokalani'nui	Read Replies (2) \| Respond to of 52153

Others will know better than I. I have no idea who has better performance, but I prefer watching orbimed just because they are more likely to have a position or close one out in a stock I own or am interested in. Merlin is a little too big and may own some pharma, and will surely have lot of idec, medi, dna and so on. BVF often does not hang around a company long enough to draw any long-term conclusions about how they assess the technology; which is what I am after. BVF definitely has an eye for bargains though. Thanks for the Oracle suggestion. Wilder